American Diabetes Association

Assessment of peripheral vascular disease in diabetes. Report and recommendations of an International Workshop sponsored by the American Heart Association and the American Diabetes Association 18-20 September 1992, New Orleans, Louisiana

1993NationalJournal of the American Podiatric Medical Association

United States

Read the PDF Original at the sourceAsk Osler about this guideline

Read the guideline

Full guideline, as published510 KBOpen in a new tab Download

Source and rights

Published by Journal of the American Podiatric Medical Association, 1993. The PDF is shown as published and remains the work of its authors and publisher; the original is at the source linked here. Rights holders can ask us to remove a file at info@prognia.nl.

Ask a question about this guideline.

Osler answers from this library and names the guideline behind every claim.

Discover Osler

www.mdpi.com/journal/japma/japma_flyer.pdf

Prognia summarises this guideline for reference and education. It is not medical advice. Always check the official guideline and current local protocols before acting on it.

At a glance

Organisation: American Diabetes Association
Published: 1993
Applies to: 🇺🇸 United States
Scope: National
Journal: Journal of the American Podiatric Medical Association
DOI: 10.7547/87507315-83-12-685
PubMed: 8283395
Added to Prognia: 24 July 2026

Who and how to screen for Cushing's syndrome: the position statement of the Italian Society of EndocrinologyWorld Health Organization · 2026Added 23 Jul 2026

Diabetes technology (Update 2026)Wiener klinische Wochenschrift · 2026Added 23 Jul 2026PDF

ISPAD Position Statement on Type 1 Diabetes in SchoolsInternational Society for Pediatric and Adolescent Diabetes · 2026Added 18 Jul 2026PDF

SICOB Italian Clinical Practice GRADE-based guidelines for the endobariatric treatment of overweight, obesity, and obesity-associated diseasesUpdates in surgery · 2026Added 18 Jul 2026PDF

Part 2: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Risk Stratifying Patients With MASLD.Dysfunction-Associated Steatotic Liver Disease Working Group · 2026Added 18 Jul 2026PDF

Part 3: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Recommendations for Ultrasound Shear Wave Elastography and MR Elastography Program Implementation, Funding, and Quality AssuranceDysfunction-Associated Steatotic Liver Disease Working Group · 2026Added 18 Jul 2026PDF

Part 1: CAR Metabolic Dysfunction-Associated Steatotic Liver Disease Working Group Guidance Statements for Detecting and Grading Hepatic Steatosis Using Ultrasound, CT, or MRI.Dysfunction-Associated Steatotic Liver Disease Working Group · 2026Added 18 Jul 2026PDF

Japan Endocrine Society Clinical Practice Guideline for the Diagnosis and Management of Pheochromocytoma and Paraganglioma 2025Endocrine Society · 2026Added 18 Jul 2026PDF

European Association for the Study of Obesity Position Statement on the Diagnosis and Management of Obesity in Older AdultsObesity facts · 2026Added 18 Jul 2026PDF

10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes-2026American Diabetes Association · 2026Added 18 Jul 2026PDF